Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07292792 · ClinicalTrials.gov registry record
The Unlocking PrEP Study: Integration of Peer Health Navigation Into Comprehensive Re-entry Services
A clinical trial of HIV Prevention and HIV Disease, sponsored by University of Texas Southwestern Medical Center.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT07292792: Recruiting study of HIV Prevention and HIV Disease, sponsored by University of Texas Southwestern Medical Center.
NCT07292792 is a study of HIV Prevention and HIV Disease that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 100 participants, below the 379-participant average among 32 other HIV Prevention trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07292792, a study of HIV Prevention and HIV Disease, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This 18-month study, "Integration of peer health navigation into comprehensive re-entry services: improving PrEP implementation for justice-involved individuals," aims to increase PrEP awareness and uptake among people with a history of justice involvement in Dallas, primarily clients of Unlocking Doors.
Primary Outcome
Feasibility will be assessed by the proportion of Unlocking Doors clients who engage with the health coach. This indicator reflects whether the health coach can be effectively integrated into existing re-entry workflows.
Conditions Studied
Interventions
- BEHAVIORAL Health Coach Intervention
Study Locations (1)
Texas
- UT Southwestern Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-05-21 |
| Est. Completion | 2026-11-21 |
What NCT07292792 shows while recruiting
NCT07292792 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 379-participant average among 32 other HIV Prevention trials with a reported enrollment target (74% lower).
The record links to 2 conditions, with HIV Prevention appearing as the primary indexed condition, and to 1 intervention - of which Health Coach Intervention is the first listed.
NCT07292792 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT07292792 about?
NCT07292792 is a clinical study titled "The Unlocking PrEP Study: Integration of Peer Health Navigation Into Comprehensive Re-entry Services". This 18-month study, "Integration of peer health navigation into comprehensive re-entry services: improving PrEP implementation for justice-involved individuals," aims to increase PrEP awareness and uptake among people with a history of justice involvement in Dallas, primarily clients of Unlocking D...
What is the current status of trial NCT07292792?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2025-05-21. Estimated completion is 2026-11-21.
What conditions does trial NCT07292792 study?
This clinical trial studies the following conditions: HIV Prevention, HIV Disease.
What interventions are being tested in trial NCT07292792?
The interventions under investigation include: Health Coach Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT07292792?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07292792 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Prevention
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07292792's enrollment target sits among peer trials
100 18th of 32 higher than 13 of 32 other HIV Prevention trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Prevention trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Using PrEP, Doing It for Ourselves
RECRUITING · NA
-
Client-Centered Care Coordination for Black Men Who Have Sex With Men
RECRUITING · NA
-
Behavioral Economic Intervention to Improve HIV Behaviors in Sexual Minority Individuals
RECRUITING · NA
-
Intervention to Enhance PrEP Persistence
RECRUITING · NA
-
Evaluation of Single Dosing With Two F/TAF Tablets Among Healthy Volunteers
RECRUITING · Phase 1
-
WePrEP: Developing a PrEP Shared Decision-making Tool for Transgender Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI